Regulatory News:
3 months ended 31 March 2013
- Local currency sales decreased by 1% and Euro sales decreased by 4% to €381.3m (€395.7m).
- Number of active consultants was up by 3% to 3.7m.
- EBITDA amounted to €45.2m (€55.0m).
- Operating margin was 10.0% (12.0%) resulting in an operating profit of €38.0m (€47.7m).
- Net profit amounted to €28.0m (€34.5m) and EPS amounted to €0.50 (€0.61).
- Cash flow from operating activities amounted to €28.4m (€58.1m).
- Second quarter update: The underlying sales growth in the second quarter to date is around 2% in local currency.
CEO Magnus Brännström comments
Our continuous efforts to build a stable platform for long term growth are gradually resulting in improved momentum. After a weak trend during the last six quarters we returned to sales force growth during the first quarter. Several initiatives have been implemented to strengthen our total offering and efficiency such as an improved Success Plan in the CIS and the opening of the new Group Distribution Centre in Moscow – while affecting the profitability short term. We continue facing challenges in Europe, however experience encouraging development in the CIS and rest of the World.
Conference call for the financial community
The company will host a conference call on Thursday, 25 April at 09.30 CET.
Participant access numbers:
Luxembourg: +352 2 786 0202
Sweden: +46 (0)8 506 443 86
Switzerland: +41 44 580 6522
UK: +44 207 153 9154
US: +1 877 423 0830
Confirmation code: 947632#
The conference call will also be audio web cast in "listen-only" mode through Oriflame's website: www.oriflame.com or through http://storm.zoomvisionmamato.com/player/oriflame/objects/xpsnqv5r/
This information was brought to you by Cision http://news.cision.com
Contacts:
Oriflame
Magnus Brännström, +352 691 151 930
Chief Executive Officer
or
Gabriel Bennet, +41 798 263 713
Chief Financial Officer
or
Anders Ågren, +46 765 422 353
VP Investor Relations
